Resistance to first-line antiretroviral therapy

Resistance to first-line antiretroviral therapy

Bibliographic Details
Main Authors:	Ramón Cámara-Reyes, Miguel Ángel Arce-Huamani, Mario Luis Franco-Soto, Juan Carlos Díaz-Monge
Format:	Article
Language:	English
Published:	Medwave Estudios Limitada 2017-05-01
Series:	Medwave
Online Access:	https://www.medwave.cl/link.cgi/Medwave/Perspectivas/Cartas/6955

Similar Items

Antiretroviral resistance in HIV-infected Saudi children failing first-line highly active antiretroviral therapy
by: Sami Hussain Al Hajjar, et al.
Published: (2012-11-01)

Reconsidering first-line antiretroviral therapy in the pregnant population
by: Yoo, Sunny
Published: (2016)

Clinically relevant transmitted drug resistance to first line antiretroviral drugs and implications for recommendations.
by: Susana Monge, et al.
Published: (2014-01-01)

Cost analysis of the first line antiretroviral therapy in Russian Federation
by: A. V. Rudakova
Published: (2014-09-01)

Comparison of efficacy and safety of antiretroviral first-line therapy with phosphazideortdf
by: A. V. Kravchenko, et al.
Published: (2018-12-01)

The end of the line? A case of drug resistance to third-line antiretroviral therapy
by: Theresa M. Rossouw, et al.
Published: (2016-05-01)

Second-line failure and first experience with third-line antiretroviral therapy in Mumbai, India
by: Samsuddin Khan, et al.
Published: (2014-07-01)

What is the optimal first line antiretroviral therapy in resource-limited settings?
by: Chris Kenyon, et al.
Published: (2012-01-01)

Previous antiretroviral drug use compromises standard first-line HIV therapy and is mediated through drug-resistance
by: Seth C. Inzaule, et al.
Published: (2018-10-01)

Incidence and types of HIV-1 drug resistance mutation among patients failing first-line antiretroviral therapy
by: Xiao-lu Luo, et al.
Published: (2019-04-01)

Assessing the Efficacy of Second-Line Antiretroviral Treatment for HIV Patients Failing First-Line Antiretroviral Therapy in Iran: A Cohort Study
by: Mehrnaz Rasooli-Nejad, et al.
Published: (2017-05-01)

Uptake of WHO recommendations for first-line antiretroviral therapy in Kenya, Uganda, and Zambia.
by: Herbert C Duber, et al.
Published: (2015-01-01)

Cost-effectiveness of early initiation of first-line combination antiretroviral therapy in Uganda
by: Sempa Joseph, et al.
Published: (2012-09-01)

Long-term virological outcome in children receiving first-line antiretroviral therapy
by: Padmapriyadarsini Chandrasekaran, et al.
Published: (2018-11-01)

Modification of First-line Antiretroviral Therapy in Treatment-naive, HIV Positive Patients
by: Smita Shenoy, et al.
Published: (2017-10-01)

Identification of HIV-1 Genotypic Resistance in Patients on First-line Antiretroviral Therapy Using Polymerase Chain Reaction and Sequencing
by: Xiao Jiang, et al.
Published: (2013-12-01)

First-line antiretroviral drug discontinuations in children.
by: Melony Fortuin-de Smidt, et al.
Published: (2017-01-01)

The first decade of antiretroviral therapy in Africa
by: Ford Nathan, et al.
Published: (2011-09-01)

Incidence of tuberculosis in HIV-infected adults on first- and second-line antiretroviral therapy in India
by: Akshay N. Gupte, et al.
Published: (2019-10-01)

Evaluation of Adverse Drug Reaction Profile of Drugs Used as First-Line Antiretroviral Therapy
by: Mukta N. Chowta, et al.
Published: (2018-01-01)

Treatment outcomes of first-line antiretroviral therapy in HIV-1-positive patients in Serbia
by: Jovana Kušić, et al.
Published: (2016-01-01)

Virologic response to efavirenz-based first-line antiretroviral therapy in children with previous exposure to antiretrovirals to prevent mother-to-child transmission.
by: Patience Nyakato, et al.
Published: (2020-01-01)

High Levels of Dual-Class Drug Resistance in HIV-Infected Children Failing First-Line Antiretroviral Therapy in Southern Ethiopia
by: Birkneh Tilahun Tadesse, et al.
Published: (2018-02-01)

HIV-1 drug resistance genotyping from antiretroviral therapy (ART) naïve and first-line treatment failures in Djiboutian patients
by: Elmi Abar Aden, et al.
Published: (2012-10-01)

Response to second line antiretroviral therapy in India
by: Singh Anup, et al.
Published: (2012-05-01)

Case report: Emergence of dolutegravir resistance in a patient on second-line antiretroviral therapy
by: Kairoonisha Mahomed, et al.
Published: (2020-07-01)

Predictors of Virological Failure in HIV Patients Receiving First Line Antiretroviral Therapy with Good Adherence
by: Farid Kurniawan, et al.
Published: (2017-03-01)

Southern African HIV Clinicians Society Guidance on the use of dolutegravir in first-line antiretroviral therapy
by: Michelle A. Moorhouse, et al.
Published: (2018-10-01)

Antiretroviral drug resistance mutations among patients failing first-line treatment in Hanoi, Vietnam
by: Tien TV, et al.
Published: (2019-05-01)

Polymorphisms and drug resistance analysis of HIV-1 isolates from patients on first line antiretroviral therapy (ART) in South-eastern Nigeria.
by: Augustine O Udeze, et al.
Published: (2020-01-01)

Frequent cross-resistance to rilpivirine among subtype C HIV-1 from first-line antiretroviral therapy failures in South Africa
by: Kerri J Penrose, et al.
Published: (2018-03-01)

Detection of minority drug resistant mutations in Malawian HIV-1 subtype C-positive patients initiating and on first-line antiretroviral therapy
by: Zhiyong Zhou, et al.
Published: (2018-05-01)

Pre-treatment HIV-drug resistance associated with virologic outcome of first-line NNRTI-antiretroviral therapy: A cohort study in Kenya
by: Ingrid A. Beck, et al.
Published: (2020-01-01)

Antiretroviral changes during the first year of therapy
by: Antonio Carlos Policarpo Carmo Sá Bandeira, et al.

Use of third line antiretroviral therapy in Latin America.
by: Carina Cesar, et al.
Published: (2014-01-01)

Adverse drug reactions to Antiretroviral drugs: Effect on virologic faliure in a Nigerian cohort of HIV-infected adults on first-line Antiretroviral therapy
by: Abah, Isaac Okoh
Published: (2018)

Predicting early and late first-line antiretroviral therapy virologic failure, and switch to second-line therapy in a military population in South Africa
by: Mhangwane, Shushu Rirhandzu Comfort
Published: (2018)

Cost-effectiveness analysis of antiretroviral therapy in a cohort of HIV-infected patients starting first-line highly active antiretroviral therapy during 6 years of observation
by: Maggiolo F, et al.
Published: (2015-02-01)

A viral genome wide association study and genotypic resistance testing in patients failing first line antiretroviral therapy in the first large countrywide Ethiopian HIV cohort
by: Nigus Fikrie Telele, et al.
Published: (2019-07-01)

High level of treatment failure and drug resistance to first-line antiretroviral therapies among HIV-infected children receiving decentralized care in Senegal
by: Abdoul-Magib Cissé, et al.
Published: (2019-02-01)

Cannot write session to /tmp/vufind_sessions/sess_qokttnhqir9sbtbtvg39t3891l